• 1. Distinguishing between polymorphic forms of linezolid by solid-phase electronic and vibrational circular dichroism?
  Jadwiga Frelek,Marcin Górecki,Marta ?aszcz,Agata Suszczyńska,Elemér Vass,Wojciech J. Szczepek Chem. Commun., 2012,48, 5295-5297
• 2. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Excitonic and vibrational coherence in artificial photosynthetic systems studied by negative-time ultrafast laser spectroscopy
  Dongjia Han,Bing Xue,Juan Du,Tomohiro Miyatake,Hitoshi Tamiaki,Xin Xing,Wei Yuan,Yanyan Li Phys. Chem. Chem. Phys., 2016,18, 24252-24260
• 5. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832

3-(Ethylcarbamoyl)benzoic Acid: A Comprehensive Overview

3-(Ethylcarbamoyl)benzoic acid, identified by the CAS number 126926-33-8, is a compound of significant interest in the fields of organic chemistry and pharmaceutical research. This compound, with its unique structure and functional groups, has garnered attention due to its potential applications in drug design and material science. Recent studies have highlighted its role in various synthetic pathways and its ability to serve as a versatile building block in organic synthesis.

The molecular structure of 3-(ethylcarbamoyl)benzoic acid comprises a benzoic acid moiety substituted with an ethylcarbamoyl group at the meta position. This substitution pattern influences the compound's chemical reactivity, solubility, and stability. Researchers have explored its synthesis through various methods, including nucleophilic aromatic substitution and coupling reactions, which have been optimized to enhance yield and purity. These advancements have been documented in recent publications, underscoring the compound's importance in modern synthetic chemistry.

In terms of applications, 3-(ethylcarbamoyl)benzoic acid has shown promise in the development of bioactive molecules. Its carboxylic acid group enables it to participate in peptide bond formation, making it a valuable precursor in the synthesis of peptides and related compounds. Additionally, its ethylcarbamoyl group contributes to hydrogen bonding capabilities, which are crucial for interactions within biological systems.

Recent studies have also investigated the pharmacological properties of derivatives of CAS 126926-33-8. These studies suggest potential anti-inflammatory and antioxidant activities, which could be harnessed for therapeutic purposes. Furthermore, computational modeling has been employed to predict the binding affinities of these derivatives to various protein targets, providing insights into their potential as drug candidates.

The synthesis and characterization of 3-(ethylcarbamoyl)benzoic acid have been facilitated by advanced analytical techniques such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry. These methods have allowed for precise determination of the compound's structure and purity, ensuring its reliability for further research and application.

In conclusion, 3-(ethylcarbamoyl)benzoic acid, with its CAS number 126926-33-8, stands as a notable compound in contemporary chemical research. Its structural versatility, combined with recent advancements in synthetic methodologies and pharmacological evaluations, positions it as a key player in the development of novel compounds with therapeutic potential. Continued exploration into its properties and applications is expected to yield further breakthroughs in the field.

• 23386-41-6(3-Oxoisoindoline-5-carboxylic acid)
• 215118-68-6(4-(tert-Butylcarbamoyl)benzoic acid)
• 23754-45-2(4-(Methylamino)carbonylbenzoic Acid)
• 72236-23-8(DCBA)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)